Regeneron Pharmaceuticals
REGN
REGN
1,263 hedge funds and large institutions have $81.3B invested in Regeneron Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 181 funds opening new positions, 443 increasing their positions, 439 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,263
Holders Change
+92
Holders Change %
+7.86%
% of All Funds
18.52%
Holding in Top 10
25
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-13.79%
% of All Funds
0.37%
New
181
Increased
443
Reduced
439
Closed
68
Calls
$1.25B
Puts
$1.93B
Net Calls
-$677M
Net Calls Change
-$494M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.15B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$419M |
| 3 |
Millennium Management
New York
|
+$214M |
| 4 |
Amundi
Paris,
France
|
+$207M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$193M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.32B |
| 2 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
-$367M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$356M |
| 4 |
BlackRock
New York
|
-$216M |
| 5 |
Neuberger Berman Group
New York
|
-$212M |